Carboplatin Dosing in Children: Calculation by Different Formulae

被引:0
|
作者
Wuerthwein, Gudrun [2 ]
Krefeld, Barbara [1 ]
Gerss, Joachim [3 ]
Boos, Joachim [1 ]
机构
[1] Univ Klinikum Munster, Klin & Poliklin Kinderheilkunde Padiatr Hamatol O, D-48129 Munster, Germany
[2] ZKS, Freiburg, Germany
[3] Univ Klinikum Munster, Abt Med Informat & Biomath, Munster, Germany
来源
ONKOLOGIE | 2011年 / 34卷 / 1-2期
关键词
Carboplatin; Dose calculation; Children; GLOMERULAR-FILTRATION-RATE; BODY-SURFACE AREA; SERUM CREATININE; POPULATION PHARMACOKINETICS; PLASMA CREATININE; RENAL-FUNCTION; SOLID TUMORS; PHASE-I; WEIGHT; HEIGHT;
D O I
10.1159/000323369
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Carboplatin dosing in children is based on renal function and there exists a wealth of formulae available for calculating the body surface area (BSA), the glomerular filtration rate (GFR), and the carboplatin dose. Patients and Methods: A fictitious group of children with different ages and body builds was 'constructed'. For comparison of formulae, bias and precision were assessed. Results: BSA calculations according to DuBois-DuBois, Gehan-George, Mosteller, and Boyd showed good agreement. GFR calculations according to the weight-based Cole formula and the Leger formula gave comparable results. Regarding GFR in young children, the weight- and creatinine-based Cole and the Schwartz formula showed clear differences. Again, carboplatin dose calculations according to Marina, Newell, and Chatelut are comparable. Moreover, the precision of the creatinine measurement has a clear influence on the result of the dose calculation. Conclusions: The choice of the GFR formula is more important for the carboplatin dose calculation compared to the BSA or dose equation. GFR calculations in children show marked, age-dependent variations. A sequence of multiple calculation steps (especially for the Schwartz and Marina formulae) may lead to considerable uncertainty and proneness to error in the clinical routine. In high-risk patients, GFR should be measured precisely and complemented by therapeutic drug monitoring.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 50 条
  • [31] Hypersensitivity to Carboplatin in Children with Malignancy
    Ruggiero, Antonio
    Rizzo, Daniela
    Catalano, Martina
    Attina, Giorgio
    Riccardi, Riccardo
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [32] Hypersensitivity reactions to carboplatin in children
    Lazzareschi, I
    Ruggiero, A
    Riccardi, R
    Attinà, G
    Colosimo, C
    Lasorella, A
    JOURNAL OF NEURO-ONCOLOGY, 2002, 58 (01) : 33 - 37
  • [33] Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers
    Samani, A.
    Bennett, R.
    Eremeishvili, K.
    Kalofonou, F.
    Whear, S.
    Montes, A.
    Kristeleit, R.
    Krell, J.
    McNeish, I
    Ghosh, S.
    Tookman, L.
    ESMO OPEN, 2022, 7 (02)
  • [34] Impact of a new assay for measuring serum creatinine levels on carboplatin dosing
    Murray, Brian
    Bates, Jill
    Buie, Larry
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (13) : 1136 - 1141
  • [35] Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate
    Dooley, MJ
    Poole, SG
    Rischin, D
    Webster, LK
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (01) : 44 - 51
  • [36] Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study
    Praiss, Aaron M.
    Miller, Austin
    Smith, Judith
    Lichtman, Stuart M.
    Bookman, Michael
    Aghajanian, Carol
    Sabbatini, Paul
    Backes, Floor
    Cohn, David E.
    Argenta, Peter
    Friedlander, Michael
    Goodheart, Michael J.
    Mutch, David G.
    Gershenson, David M.
    Tewari, Krishnansu S.
    Wenham, Robert M.
    Hendrickson, Andrea E. Wahner
    Lee, Roger B.
    Gray, Heidi
    Secord, Angeles Alvarez
    Van Le, Linda
    O'Cearbhaill, Roisin E.
    GYNECOLOGIC ONCOLOGY, 2023, 174 : 213 - 223
  • [37] Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy
    Rubie, H
    Doz, F
    Vassal, G
    Chastagner, P
    Gentet, JC
    Urien, S
    Bastian, G
    Drouard-Troalen, L
    Barberi-Heyob, M
    Catalin, J
    Chatelut, E
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (10) : 1433 - 1438
  • [38] Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with wilms tumour
    Daw, Najat C.
    Gregornik, David
    Rodman, John
    Marina, Neyssa
    Wu, Jianrong
    Kun, Larry E.
    Jenkins, Jesse J.
    McPherson, Valerie
    Wilimas, Judith
    Jones, Deborah P.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 99 - 106
  • [39] Drug dosing in children with obesity: a narrative updated review
    Gaeta, Francesca
    Conti, Valeria
    Pepe, Angela
    Vajro, Pietro
    Filippelli, Amelia
    Mandato, Claudia
    ITALIAN JOURNAL OF PEDIATRICS, 2022, 48 (01)
  • [40] Improving Carboplatin Dosing Based on Estimated GFR
    Beumer, Jan H.
    Inker, Lesley A.
    Levey, Andrew S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (02) : 163 - 165